Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Baumert

Showing results (41-50 of 385) with videos related to

Pageof 39
Sort By:
Medecine Sciences : M/S|April 28, 2025
[The circadian clock: a new therapeutic target for liver fibrosis]Émilie Crouchet, Catherine Schuster, Thomas F Baumert
Expert Review of Proteomics|June 20, 2017
Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impactEmilie Crouchet, Thomas F Baumert, Catherine Schuster
Metabolism: Clinical and Experimental|August 16, 2020
Perturbation of the circadian clock and pathogenesis of NAFLDAtish Mukherji, Mayssa Dachraoui, Thomas F Baumert
Hepatology (Baltimore, Md.)|April 15, 2025
Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus-host immune interactionsPierre Tonnerre, Yujin Hoshida, Thomas F Baumert
Hepatobiliary Surgery and Nutrition|November 9, 2020
FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance?Antonio Saviano, Simona Tripon, Thomas F Baumert
Hepatology (Baltimore, Md.)|March 5, 2011
Triglyceride synthesis and hepatitis C virus production: identification of a novel host factor as antiviral targetCatherine Schuster, Mathieu Lefèvre, Thomas F Baumert
Frontiers in Immunology|November 27, 2018
Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus VaccineSteven K H Foung, Thomas F Baumert
Seminars in Liver Disease|April 22, 2024
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular CarcinomaAntonio Saviano, Natascha Roehlen, Thomas F Baumert
Viruses|August 21, 2019
The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to HumansKarim Majzoub, Florian Wrensch, Thomas F Baumert
Journal of Hepatology|January 15, 2008
RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycleJoachim Lupberger, Laurent Brino, Thomas F Baumert
Pageof 39

Showing results (41-50 of 385) with videos related to

Sort By:
Pageof 39
Medecine Sciences : M/S|April 28, 2025
[The circadian clock: a new therapeutic target for liver fibrosis]Émilie Crouchet, Catherine Schuster, Thomas F Baumert
Expert Review of Proteomics|June 20, 2017
Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impactEmilie Crouchet, Thomas F Baumert, Catherine Schuster
Metabolism: Clinical and Experimental|August 16, 2020
Perturbation of the circadian clock and pathogenesis of NAFLDAtish Mukherji, Mayssa Dachraoui, Thomas F Baumert
Hepatology (Baltimore, Md.)|April 15, 2025
Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus-host immune interactionsPierre Tonnerre, Yujin Hoshida, Thomas F Baumert
Hepatobiliary Surgery and Nutrition|November 9, 2020
FIB-4 score and hepatocellular carcinoma risk after hepatitis C virus cure: time to revise surveillance?Antonio Saviano, Simona Tripon, Thomas F Baumert
Hepatology (Baltimore, Md.)|March 5, 2011
Triglyceride synthesis and hepatitis C virus production: identification of a novel host factor as antiviral targetCatherine Schuster, Mathieu Lefèvre, Thomas F Baumert
Frontiers in Immunology|November 27, 2018
Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus VaccineSteven K H Foung, Thomas F Baumert
Seminars in Liver Disease|April 22, 2024
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular CarcinomaAntonio Saviano, Natascha Roehlen, Thomas F Baumert
Viruses|August 21, 2019
The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to HumansKarim Majzoub, Florian Wrensch, Thomas F Baumert
Journal of Hepatology|January 15, 2008
RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycleJoachim Lupberger, Laurent Brino, Thomas F Baumert
Pageof 39